CPI-455

CAS : 1628208-23-0

Ref. 3D-DQC20823

Informations sur le produit

• Nom: CPI-455

Description

CPI-455 is a small molecule that inhibits the lysine methyltransferase (KMT) family of enzymes. It has been shown to inhibit the proliferation of prostate cancer cells and induce apoptosis in vitro. CPI-455 also prevents transcriptional regulation by inhibiting the ubiquitination of histone H3 on lysine 9, which is an important epigenetic modification for gene expression. This drug also has synergistic effects with other agents, including dextran sulfate, which are used to treat cancer. The chemical biology of CPI-455 is being investigated in order to better understand its mechanism of action and potential therapeutic uses.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 278.31 g/mol
• Formule: C₁₆H₁₄N₄O
• Degré de pureté: Min. 95%